ALKEMY CAPITAL INVESTMENTS PLC financials
ALKEMY CAPITAL INVESTMENTS PLC
213800NW5GVIRMXSRL48 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Other income | £235 | £0 |
| Administrative expenses | £1.7M | £1.2M |
| Finance costs | £532.7K | £135.1K |
| Profit before tax | -£2.5M | -£1.4M |
| Income tax expense | £0 | £0 |
| Profit for the year | -£2.5M | -£1.4M |
| Total comprehensive income | -£2.5M | -£1.4M |
| Per share | ||
| Basic EPS | £-0.25 | £-0.16 |
| Cash flow statement | ||
| Net cash from operating activities | -£1.1M | -£369.1K |
| Net cash from investing activities | -£1.9M | -£28.1K |
| Purchase of intangibles | £1.9M | £28.1K |
| Net cash from financing activities | £3.1M | £370.9K |
| Proceeds from borrowings | £2.2M | £370.9K |
| Repayments of borrowings | £966.0K | £0 |
| Net change in cash | £136.6K | -£26.4K |
| Balance sheet | ||
| Total assets | £4.1M | £570.7K |
| Non-current assets | £3.8M | £506.2K |
| Current assets | £294.6K | £64.5K |
| Trade & other receivables | £141.3K | £47.8K |
| Cash & equivalents | £153.3K | £16.7K |
| Total equity | -£707.4K | -£1.5M |
| Long-term borrowings | £1.1M | £0 |
| Current liabilities | £3.6M | £2.1M |
| Short-term borrowings | £904.9K | £599.4K |
| Trade & other payables | £2.7M | £1.5M |
| Derived metrics | ||
| Return on equity | 351.7% | 93.2% |
| Cash conversion ratio | 0.44× | 0.26× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade Account Receivable | £6.4K | £78.5K |
| Adjustments For Finance Costs | £532.7K | £135.1K |
| Adjustments For Increase Decrease In Trade Account Payable | -£381.0K | £483.8K |
| Adjustments For Sharebased Payments | £151.2K | £359.9K |
| Changes In Equity | £3.6M | £429.3K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£13 | -£2.4K |
| Equity and Liabilities | £4.1M | £570.7K |
| Gains Losses On Exchange Differences On Translation Before Tax | -£71.3K | £1.0K |
| Gains Losses On Exchange Differences On Translation Net of Tax | -£13 | -£13.0K |
| Increase Decrease Through Sharebased Payment Transactions | £362.6K | £429.3K |
| Intangible Assets Other Than Goodwill | £3.8M | £506.2K |
| Issue of Equity | £3.2M | — |
| Issued Capital | £213.3K | £176.3K |
| Liabilities | £4.8M | £2.1M |
| Proceeds From Issuing Shares | £1.9M | £0 |
| Retained Earnings | -£9.1M | -£6.6M |
| Share Premium | £7.2M | £4.3M |
Every line item above is a fact tagged in ALKEMY CAPITAL INVESTMENTS PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.